Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients
Abstract Owing to its narrow therapeutic range and high pharmacokinetic variability, optimal dosing for busulfan is important to minimise overexposure-related systemic toxicity and underexposure-related graft failure. Using global metabolomics, we investigated biomarkers for predicting busulfan expo...
Guardado en:
Autores principales: | Bora Kim, Ji Won Lee, Kyung Taek Hong, Kyung-Sang Yu, In-Jin Jang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn, Joo-Youn Cho, Hyoung Jin Kang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06cab8cab19242ea84e84676399eeb22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Ömer Faruk Bahçecioğlu, et al.
Publicado: (2021) -
In vivo enrichment of busulfan-resistant germ cells for efficient production of transgenic avian models
por: Young Min Kim, et al.
Publicado: (2021) -
Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions
por: Bianca A. W. Hoeben, et al.
Publicado: (2021) -
Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
por: Scott S. Graves, et al.
Publicado: (2021) -
Pharmacometabolomics identifies candidate predictor metabolites of an L‐carnitine treatment mortality benefit in septic shock
por: Michael A. Puskarich, et al.
Publicado: (2021)